|
Ontology
|
ID
|
Description
|
P value
|
FDR
|
| BP |
0006954 |
inflammatory response |
4.41E-98 |
2.71E-94 |
| BP |
0042493 |
response to drug |
9.21E-58 |
2.83E-54 |
| BP |
0006955 |
immune response |
2.16E-55 |
4.43E-52 |
| BP |
0045087 |
innate immune response |
1.08E-48 |
1.66E-45 |
| BP |
0032496 |
response to lipopolysaccharide |
2.50E-46 |
3.08E-43 |
| BP |
0001666 |
response to hypoxia |
5.70E-43 |
5.19E-40 |
| BP |
0043066 |
negative regulation of apoptotic process |
5.90E-43 |
5.19E-40 |
| BP |
0008284 |
positive regulation of cell proliferation |
7.95E-41 |
6.11E-38 |
| BP |
0051092 |
positive regulation of NF-kappaB transcription factor activity |
3.14E-39 |
2.15E-36 |
| BP |
0050900 |
leukocyte migration |
1.88E-37 |
1.16E-34 |
| BP |
0071222 |
cellular response to lipopolysaccharide |
4.05E-36 |
2.26E-33 |
| BP |
0045944 |
positive regulation of transcription from RNA polymerase II promoter |
1.28E-35 |
6.58E-33 |
| BP |
0007165 |
signal transduction |
1.86E-34 |
8.82E-32 |
| BP |
0070374 |
positive regulation of ERK1 and ERK2 cascade |
6.05E-33 |
2.66E-30 |
| BP |
0007568 |
aging |
1.46E-32 |
6.01E-30 |
| BP |
0045471 |
response to ethanol |
2.73E-32 |
1.05E-29 |
| BP |
0010628 |
positive regulation of gene expression |
2.58E-30 |
9.35E-28 |
| BP |
0045766 |
positive regulation of angiogenesis |
2.86E-30 |
9.79E-28 |
| BP |
0006915 |
apoptotic process |
1.04E-29 |
3.36E-27 |
| BP |
0050731 |
positive regulation of peptidyl-tyrosine phosphorylation |
3.21E-29 |
9.89E-27 |
| CC |
0005615 |
extracellular space |
3.41E-141 |
2.46E-138 |
| CC |
0005576 |
extracellular region |
1.01E-97 |
3.64E-95 |
| CC |
0070062 |
extracellular exosome |
5.69E-82 |
1.37E-79 |
| CC |
0009986 |
cell surface |
1.58E-54 |
2.85E-52 |
| CC |
0005886 |
plasma membrane |
3.42E-54 |
4.94E-52 |
| CC |
0009897 |
external side of plasma membrane |
1.55E-51 |
1.87E-49 |
| CC |
0005829 |
cytosol |
1.28E-44 |
1.32E-42 |
| CC |
0045121 |
membrane raft |
2.26E-37 |
2.04E-35 |
| CC |
0005925 |
focal adhesion |
4.75E-33 |
3.82E-31 |
| CC |
0005887 |
integral component of plasma membrane |
7.79E-32 |
5.63E-30 |
| CC |
0016020 |
membrane |
1.32E-28 |
8.68E-27 |
| CC |
0072562 |
blood microparticle |
4.56E-26 |
2.75E-24 |
| CC |
0031012 |
extracellular matrix |
4.24E-24 |
2.36E-22 |
| CC |
0031093 |
platelet alpha granule lumen |
8.12E-21 |
4.20E-19 |
| CC |
0043202 |
lysosomal lumen |
2.13E-18 |
1.03E-16 |
| CC |
0043234 |
protein complex |
1.55E-17 |
6.82E-16 |
| CC |
0048471 |
perinuclear region of cytoplasm |
1.60E-17 |
6.82E-16 |
| CC |
0005764 |
lysosome |
2.36E-17 |
9.47E-16 |
| CC |
0005796 |
Golgi lumen |
1.88E-14 |
7.16E-13 |
| CC |
0005911 |
cell-cell junction |
5.39E-13 |
1.95E-11 |
| MF |
0005515 |
protein binding |
7.49E-56 |
1.32E-52 |
| MF |
0005102 |
receptor binding |
1.57E-42 |
1.38E-39 |
| MF |
0019899 |
enzyme binding |
1.75E-31 |
1.03E-28 |
| MF |
0042803 |
protein homodimerization activity |
2.56E-31 |
1.13E-28 |
| MF |
0042802 |
identical protein binding |
7.35E-29 |
2.59E-26 |
| MF |
0005125 |
cytokine activity |
3.02E-27 |
8.89E-25 |
| MF |
0008083 |
growth factor activity |
1.62E-20 |
4.09E-18 |
| MF |
0002020 |
protease binding |
5.13E-20 |
1.13E-17 |
| MF |
0004872 |
receptor activity |
7.69E-19 |
1.51E-16 |
| MF |
0001618 |
virus receptor activity |
2.08E-18 |
3.67E-16 |
| MF |
0019901 |
protein kinase binding |
3.64E-18 |
5.83E-16 |
| MF |
0005088 |
Ras guanyl-nucleotide exchange factor activity |
1.84E-16 |
2.70E-14 |
| MF |
0005179 |
hormone activity |
2.08E-16 |
2.83E-14 |
| MF |
0008201 |
heparin binding |
6.82E-16 |
8.60E-14 |
| MF |
0001948 |
glycoprotein binding |
7.96E-16 |
9.36E-14 |
| MF |
0004252 |
serine-type endopeptidase activity |
3.97E-15 |
4.38E-13 |
| MF |
0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
1.00E-14 |
1.04E-12 |
| MF |
0004713 |
protein tyrosine kinase activity |
2.83E-14 |
2.77E-12 |
| MF |
0005164 |
tumor necrosis factor receptor binding |
1.30E-13 |
1.20E-11 |
| MF |
0005178 |
integrin binding |
1.36E-13 |
1.20E-11 |
